Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Kyocera Corporation    6971   JP3249600002


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

KYOCERA : and Tokyo Medical and Dental University Begin Joint Research on Vitals Measurement Headset

share with twitter share with LinkedIn share with facebook
06/29/2020 | 08:08am EDT

Kyocera Corporation and Tokyo Medical and Dental University (TMDU) announced a joint research project to develop a wireless headset that can remotely monitor high accuracy patient biometrics, such as blood oxygen saturation (SpO2). The Department of Cardiovascular Medicine of TMDU Medical Hospital began preparing for clinical research of the wearable headset system in May 2020.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200629005243/en/

A physical therapist in the Rehabilitation Center at TMDU tests an early prototype wearable headset system. (Photo: Business Wire)

A physical therapist in the Rehabilitation Center at TMDU tests an early prototype wearable headset system. (Photo: Business Wire)

Coronavirus Rehabilitation Activities at Tokyo Medical and Dental University

The Rehabilitation Center at TMDU Medical Hospital has introduced rehabilitation therapy for severely ill COVID-19 patients and remote rehabilitation for moderately ill patients who have recovered enough to walk independently. Aimed at helping patients recover faster, this will also help contribute to limiting infection risk for rehabilitation staff and preserving vital medical PPE for other uses. Dr. Tomoko Sakai, director of the rehabilitation center, explains, “The role of the rehabilitation center is important for recovering COVID-19 patients because of their tendency to develop thrombosis (blood clots) and cerebral infarctions (strokes).” This rehabilitation program has been well received by many patients as a way to help improve muscle strength, relieve stress, and facilitate psychological care.

Joint Research Background 

In order to perform this kind of rehabilitation treatment, the Department of Cardiovascular Medicine of TMDU Medical Hospital proposed to incorporate the wearable headset system in joint research with Kyocera. The project is aimed at bringing remote telemedicine to rehabilitation for patients with COVID-19, and has started preparation for clinical research on the wearable headset system.

Benefits of Introducing a Headset System

A prototype in development can allow healthcare providers to check patient biometrics, such as blood oxygen saturation (SpO2) during rehabilitation in real time while communicating over standard wireless phone networks. It also allows medical professionals a more thorough evaluation and shortening the time of medical care. The new headset system incorporates bone-conduction audio technology instead of a traditional microphone and loudspeaker. This technology helps cancel unwanted ambient noise while letting patients move their limbs freely during exercise. Future development goals include miniaturizing the headset to allow convenient, real-time biometric monitoring of patients during at-home recuperation.

Kyocera Corporation and TMDU will continue the trial operation in Japan to verify the effectiveness of remote medical care and rehabilitation for patients and examine the system’s potential for treating other ailments.


Kyocera Corporation (TOKYO: 6971, https://global.kyocera.com/), the parent and global headquarters of the Kyocera Group, was founded in 1959 as a producer of fine ceramics (also known as “advanced ceramics”). By combining these engineered materials with metals and integrating them with other technologies, Kyocera has become a leading supplier of industrial and automotive components, semiconductor packages, electronic devices, smart energy systems, printers, copiers, and mobile phones. During the year ended March 31, 2020, the company’s consolidated sales revenue totaled 1.6 trillion yen (approx. US$14.7 billion). Kyocera is ranked #655 on Forbes magazine’s 2019 “Global 2000” list of the world’s largest publicly traded companies.

About Tokyo Medical and Dental University (TMDU)

TMDU is located in the Yushima / Shoheizaka area, which is considered the sacred birthplace of scholarship and learning in Japan. As a comprehensive medical university, TMDU cultivates “professionals with knowledge and humanity” who embark on a lifetime of service, advancing the health and social welfare of people in the local community and spreading their wings to do the same in other communities across the globe.

© Business Wire 2020
share with twitter share with LinkedIn share with facebook
08/10REGENEUS LTD (ASX : RGS) and Kyocera Sign Progenza OA Deal
08/06KYOCERA : Holiday Schedule KYOCERA Corporation Japan Operations to Close for Sum..
08/03KYOCERA : Seiko Instruments and GoCanvas Launch Unique Mobile Printing Solution ..
07/30KYOCERA : Fiscal 1Q Earnings Snapshot
07/30KYOCERA : Announces Consolidated Financial Results for Three Months Ended June 3..
07/30KYOCERA : Consolidated Financial Results for the Three Months Ended June 30, 202..
07/30KYOCERA : Quarterly Trends of Financial Results〔IFRS〕
07/30KYOCERA : Conference Call Material (For the Three Months Ended June 30, 2020)
07/27REGENEUS LTD (ASX : RGS) Progenza OA Kyocera Negotiations Update
07/24KYOCERA : Begins Test on Japan's First 'Self-Wheeling'
More news
Sales 2021 1 472 B 13 784 M 13 784 M
Net income 2021 86 146 M 807 M 807 M
Net cash 2021 393 B 3 679 M 3 679 M
P/E ratio 2021 26,3x
Yield 2021 2,08%
Capitalization 2 239 B 20 943 M 20 977 M
EV / Sales 2021 1,25x
EV / Sales 2022 1,17x
Nbr of Employees 75 505
Free-Float -
Duration : Period :
Kyocera Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KYOCERA CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 6 600,00 JPY
Last Close Price 6 179,00 JPY
Spread / Highest target 37,6%
Spread / Average Target 6,81%
Spread / Lowest Target -17,5%
EPS Revisions
Hideo Tanimoto President & Representative Director
Goro Yamaguchi Chairman
Masahiro Inagaki Senior Executive Officer, General Manager-R&D
Shoichi Aoki Director & General Manager-Business Administration
Robert E. Whisler Director